Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015. - Wikidata - wikimedia - TriplyDB

Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.

Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.

http://www.wikidata.org/entity/Q30249468

about

Therapeutic Response to Twice-daily Rabeprazole on Health-related Quality of Life and Symptoms in Patients with Refractory Reflux Esophagitis: A Multicenter Observational Study.Helicobacter pylori infection status had no influence on upper gastrointestinal symptoms: a cross-sectional analysis of 3,005 Japanese subjects without upper gastrointestinal lesions undergoing medical health checkups.Additive effect of rikkunshito, an herbal medicine, on chemotherapy-induced nausea, vomiting, and anorexia in uterine cervical or corpus cancer patients treated with cisplatin and paclitaxel: results of a randomized phase II study (JORTC KMP-02).What are the differences in the outcome of laparoscopic axial (I) versus paraesophageal (II-IV) hiatal hernia repair?Endoscopic findings of esophagogastric junction in children.Current Knowledge and Perspectives on Histamine H1 and H2 Receptor Pharmacology: Functional Selectivity, Receptor Crosstalk, and Repositioning of Classic Histaminergic Ligands.Reflux esophagitis and its role in the pathogenesis of Barrett's metaplasia.Pathogenesis of Double-Dose Proton Pump Inhibitor-Resistant Non-Erosive Reflux Disease, and Mechanism of Reflux Symptoms and Gastric Acid Secretion-Suppressive Effect in the Presence or Absence of Helicobacter pylori Infection.Effectiveness of proton pump inhibitor in unexplained chronic cough.Risk Factors for Helicobacter pylori Infection and Endoscopic Reflux Esophagitis in Healthy Young Japanese Volunteers.Factors Associated with Potassium-Competitive Acid Blocker Non-Response in Patients with Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease.Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use.Different effects of dietary factors on reflux esophagitis and non-erosive reflux disease in 11,690 Korean subjects.Influence of food on the gastric motor effect of the Kampo medicine rikkunshito in rat.Revisiting the Therapeutic Potential of Bothrops jararaca Venom: Screening for Novel Activities Using Connectivity Mapping.Pharmacokinetics and Pharmacodynamics of Azeloprazole Sodium, a Novel Proton Pump Inhibitor, in Healthy Japanese Volunteers.Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study.Efficacy of vonoprazan for 24-week maintenance therapy of patients with healed reflux esophagitis refractory to proton pump inhibitors.Rationale and design of the VISION study: a randomized, open-label study to evaluate the long-term safety of vonoprazan as maintenance treatment in patients with erosive esophagitis.Endoscopic diagnosis of hiatus hernia under deep inspiration is not consistent with esophageal manometric diagnosis.Recent Advances in the Pharmacological Management of Gastroesophageal Reflux Disease.Study for every other day administration of vonoprazan in maintenance treatment of erosive GERD: study protocol for a multicentre randomised cross-over study.Modulation of the oxidative plasmatic state in gastroesophageal reflux disease with the addition of rich water molecular hydrogen: A new biological vision.Efficacy of Vonoprazan for Proton Pump Inhibitor-Resistant Reflux Esophagitis.Efficacy of Vonoprazan for Gastroesophageal Reflux Symptoms in Patients with Proton Pump Inhibitor-resistant Non-erosive Reflux Disease.Management of gastroesophageal reflux disease in adults: a pharmacist’s perspective.Factors associated with the presentation of erosive esophagitis symptoms in health checkup subjects: A prospective, multicenter cohort study.Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use.Study of the prevalence of gastroesophageal reflux symptoms and the role of each in relation to the GERD Impact Scale, based on a population of patients admitted for laparoscopic surgery compared to a control group.Pathophysiology of Potassium-competitive Acid Blocker-refractory Gastroesophageal Reflux and the Potential of Potassium-competitive Acid Blocker Test Is There a Reason for the Proton Pump Inhibitor? An Assessment of Prescribing for Residential Care Patients in British Columbia

P2860

Q32182541-323A33CB-A560-4FD1-89B9-366760E1F85D Q33840330-B5FBE8AB-694F-4F99-BB6A-809E5C1DBF91 Q38705385-35462D05-8C7B-4803-A978-A9D9DF0494AA Q38734929-89664B61-748D-4F08-9377-3D1ED6BB12F5 Q38829143-B2C1921C-4AA7-440F-8F8C-B5F903A14C9A Q38953768-DD5E0B47-FA36-4E93-A1C4-7B7EFC312F51 Q39268802-F6F6E956-2279-47BD-84FF-E7849D77F680 Q40345111-637C6E55-0CE5-4B07-9E11-F23F3C143B9F Q42706776-9BB7ECEF-AC1D-4C95-A9FE-C6089157B074 Q47100510-80693346-5D28-4A6D-AA33-557394D38EDD Q47731619-15AFCE55-8D4B-4D0D-9576-780BE963FE5A Q47742865-76774021-E338-428F-A961-691284F96F50 Q48053129-E478ECAB-2443-463B-9E5A-8976AE881B18 Q48056563-496245A1-CC01-49E0-97C5-765592395F9C Q48507956-AC92CC8A-57E3-4AEA-877A-AC4F73D1054F Q49381732-7F9E3FC8-7E4B-4464-A55E-CDDBC8244C4A Q49502751-F9D638F0-7566-47C4-9B47-8A059D46BB0B Q49630186-A6416D34-A1B6-425C-A2C5-EB6214436103 Q49727148-AC412B0B-BC6D-463E-BDF3-3AEDC0694EF8 Q50093750-26F205A4-3395-4852-A793-4EB150D867A3 Q50129556-A97BD669-B33C-4CFA-AA7E-685DBD946EFB Q51741477-7D825E50-85D9-4C83-96AD-A8942200DBBE Q51765253-ED5471C8-67FD-41B8-8826-2D0659551290 Q53511062-03A968B2-03FA-4D9A-BA3C-A06CA797AB7D Q54388629-DC0542F1-A649-465D-9B80-51611ED86F16 Q55001719-46D07B8E-17BE-4D6F-AC97-03232B3B99F5 Q55437189-DF68154F-32DD-4898-8DD3-E4F14F05E29A Q55493690-EEEC29D9-5A9D-46D1-A8D2-1481BA36D141 Q55645785-0C59B8EE-8225-40A0-90DC-6DE234B49921 Q57819648-428D00F2-D032-49C4-B7AF-73D725B441F4 Q58557258-2DAAB902-5823-469A-8EC6-C6FE730DE25B

P2860

Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.

http://www.wikidata.org/entity/Q30249468

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

name

Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.

@ast

Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.

@en

type

label

Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.

@ast

Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.

@en

prefLabel

Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.

@ast

Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.

@en

P1433

Q30249468-AA2DE3AE-E8A9-49EF-AB53-EF5B3E940ACA

P1476

Q30249468-9DE1D931-6EEF-4DD3-9B81-D43ED536135C

P2093

Q30249468-0028D346-AE38-4FEB-9648-AD8C67C81A0B

Q30249468-04E7E5A2-ABA2-4130-B6DD-AEC1DCF7FC66

Q30249468-05DF5903-1145-4DAA-B1EF-1C8A370F2F8C

Q30249468-08009D17-5405-4A77-A19E-763BF6C62B86

Q30249468-4152B3A1-CD60-4BE1-8145-8AF3E8D2FCAD

Q30249468-4C46A802-B3A1-4707-A220-BAC2535C6934

Q30249468-569AFBC5-F8F5-477D-963D-7A2FC831D88A

Q30249468-57043EB7-251A-44C3-BCFD-2F66EACF820D

Q30249468-61945D04-5D93-4CA6-AE53-5A8238850492

Q30249468-68CB8DC0-CFB8-4728-866C-39BBC4E00F3B

P2860

Q30249468-05FF68B4-74BE-4D1C-BA15-4238382F5CAB

Q30249468-084E8CAD-8A32-41A9-9406-61D42905AA37

Q30249468-0B8C5BDA-36C9-4DC6-8E77-7A41783DA043

Q30249468-0CEF9D94-A5C1-4D5D-92A7-991E8B67E2F4

Q30249468-0F6E1BCD-7E13-452E-B86B-896FDF89C36D

Q30249468-14040598-BED4-47B4-850E-EEADD77F8AFF

Q30249468-1427481C-5B6D-4266-A14B-49E6F18A8ECE

Q30249468-14D80060-5C4C-4FC9-BBFB-245583C12F7E

Q30249468-15107D90-D5BF-4DB7-889E-F2C6CEBD3C6C

Q30249468-15B13FCE-D89F-426C-A981-6F081C3E4309

P304

Q30249468-031E090F-880A-4E73-967A-053B4CB2C043

P31

Q30249468-3AC3CC77-25AB-43BF-80CF-7C85A7FFA344

P356

Q30249468-69A45A19-273E-47C0-AC57-C86213053CB6

P433

Q30249468-F0024C3D-6D4D-4C78-8AF3-395137B39916

P478

Q30249468-7F1DAB8A-242E-40AC-AA75-9A761EFBE409

P50

Q30249468-8A342B48-90C1-495D-A5E3-3A06B56FD26D

P577

Q30249468-352DB25A-6952-4BBC-88C6-8E9491E94246

P698

Q30249468-BA35427D-5AF5-4D81-814B-647A600CEF4D

P921

Q30249468-F347B5BE-4B57-40DA-83CA-69841B8C16E6

P356

S00535-016-1227-8

P1433

Journal of Gastroenterology

P1476

Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015

@en

P2093

Akihito Nagahara

http://www.w3.org/2001/XMLSchema#string

Hideyuki Kashiwagi

http://www.w3.org/2001/XMLSchema#string

Hiroto Miwa

http://www.w3.org/2001/XMLSchema#string

Katsuhiko Iwakiri

http://www.w3.org/2001/XMLSchema#string

Kazuhide Higuchi

http://www.w3.org/2001/XMLSchema#string

Kazuma Fujimoto

http://www.w3.org/2001/XMLSchema#string

Ken Haruma

http://www.w3.org/2001/XMLSchema#string

Kentaro Sugano

http://www.w3.org/2001/XMLSchema#string

Kiyoshi Ashida

http://www.w3.org/2001/XMLSchema#string

Kyoichi Adachi

http://www.w3.org/2001/XMLSchema#string

P2860

Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease

Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease

Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification

Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus

Proton pump inhibitor use and risk of colorectal cancer: a population-based, case-control study

Meta-analysis: comparing the efficacy of proton pump inhibitors in short-term use.

Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months.

Comparison of outcomes twelve years after antireflux surgery or omeprazole maintenance therapy for reflux esophagitis.

Importance of pH control in the management of GERD.

Systematic review and meta-analysis of laparoscopic Nissen (posterior total) versus Toupet (posterior partial) fundoplication for gastro-oesophageal reflux disease.

P304

751-767

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00535-016-1227-8

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P50

Tadayuki Oshima

P577

2016-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27325300

http://www.w3.org/2001/XMLSchema#string

P921

gastroesophageal reflux disease